We are live on
!
Find out more
VOYA Investment Management Portfolio holdings
AUM
$96.1B
1-Year Est. Return
40.06%
This Fund
S&P 500
This Quarter
Est. Return
+5.06%
1 Year Est. Return
+40.06%
3 Year Est. Return
+122.14%
5 Year Est. Return
+169.19%
10 Year Est. Return
+659.21%
AUM
$47B
AUM Growth
+$127M
(+0.27%)
Cap. Flow
-$1.58B
Cap. Flow
% of AUM
-3.36%
Top 10 Holdings %
Top 10 Hldgs %
15.6%
Holding
2,719
New
139
Increased
718
Reduced
1,605
Closed
117
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alphabet (Google) Class A
GOOGL
|
+$278M |
| 2 |
Amphenol
APH
|
+$213M |
| 3 |
Baxter International
BAX
|
+$193M |
| 4 |
Hilton Worldwide
HLT
|
+$189M |
| 5 |
Altria Group
MO
|
+$175M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NetApp
NTAP
|
+$302M |
| 2 |
Ameriprise Financial
AMP
|
+$286M |
| 3 |
Dollar Tree
DLTR
|
+$268M |
| 4 |
Union Pacific
UNP
|
+$255M |
| 5 |
Lam Research
LRCX
|
+$231M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 21.01% |
| 2 | Consumer Discretionary | 13.42% |
| 3 | Healthcare | 13.35% |
| 4 | Financials | 12.43% |
| 5 | Industrials | 11.98% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
301
Target
TGT
$67.7B
| $32.8M | 0.07% |
431,281
+56,158
| +15% | +$4.13M |
|
302
Ultragenyx Pharmaceutical
RARE
$2.58B
| $32.8M | 0.07% |
426,788
+408,403
| +2,221% | +$26.4M |
|
303
Biogen
BIIB
$30.9B
| $32.8M | 0.07% |
112,936
-11,393
| -9% | -$3.2M |
|
304
Timken Company
TKR
$8.9B
| $32.6M | 0.07% |
748,308
-228,638
| -23% | -$10.7M |
|
|
WBC
305
DELISTED
WABCO HOLDINGS INC.
WBC
| $32.4M | 0.07% |
277,214
-155,509
| -36% | -$19.8M |
|
306
Marriott International
MAR
$91.6B
| $32.4M | 0.07% |
255,615
-68,064
| -21% | -$9.25M |
|
|
LOXO
307
DELISTED
Loxo Oncology, Inc
LOXO
| $32.3M | 0.07% |
186,422
+661
| +0.4% | +$99.3K |
|
|
INVX
308
Innovex International
INVX
$1.95B
| $32.3M | 0.07% |
629,154
+131,386
| +26% | +$6.12M |
|
|
TSS
309
DELISTED
Total System Services, Inc.
TSS
| $32.1M | 0.07% |
379,892
+176,543
| +87% | +$15.2M |
|
310
Saia
SAIA
$9.76B
| $32.1M | 0.07% |
396,859
-122,040
| -24% | -$9.42M |
|
311
BioMarin Pharmaceuticals
BMRN
$12.4B
| $32M | 0.07% |
340,077
-15,825
| -4% | -$1.39M |
|
312
Zions Bancorporation
ZION
$10.3B
| $31.9M | 0.07% |
605,501
-298,503
| -33% | -$16.5M |
|
313
Blackrock
BLK
$177B
| $31.9M | 0.07% |
63,849
+1,138
| +2% | +$601K |
|
314
CenterPoint Energy
CNP
$26.5B
| $31.6M | 0.07% |
1,142,113
+262,940
| +30% | +$6.9M |
|
315
Citizens Financial Group
CFG
$30.7B
| $31.6M | 0.07% |
811,873
-1,811,037
| -69% | -$75.4M |
|
|
IMMU
316
DELISTED
Immunomedics Inc
IMMU
| $31.6M | 0.07% |
1,333,820
+1,288,515
| +2,844% | +$25.9M |
|
317
Cousins Properties
CUZ
$4.85B
| $31.5M | 0.07% |
813,549
-28,027
| -3% | -$1.02M |
|
318
Tyson Foods
TSN
$20.3B
| $31.3M | 0.07% |
454,609
+75,763
| +20% | +$5.27M |
|
319
Colgate-Palmolive
CL
$73.9B
| $31M | 0.07% |
478,798
+27,892
| +6% | +$1.82M |
|
|
MGLN
320
DELISTED
Magellan Health Services, Inc.
MGLN
| $31M | 0.07% |
323,341
-27,599
| -8% | -$2.65M |
|
|
FNSR
321
DELISTED
Finisar Corp
FNSR
| $31M | 0.07% |
1,722,536
+567,318
| +49% | +$9.39M |
|
322
Allstate
ALL
$67.6B
| $31M | 0.07% |
339,211
-1,195,406
| -78% | -$114M |
|
323
Danaher
DHR
$144B
| $30.9M | 0.07% |
353,566
+532
| +0.2% | +$47.4K |
|
|
UCB
324
United Community Banks
UCB
$4.28B
| $30.9M | 0.07% |
1,006,029
+944,889
| +1,545% | +$30.8M |
|
325
FedEx
FDX
$75.6B
| $30.9M | 0.07% |
135,884
+3,550
| +3% | +$879K |
|
Similar funds
VOYA Investment Management's Q2 2018 Portfolio in Review
As of Q2 2018, VOYA Investment Management held 2,719 positions worth $47B, up 0.27% from $46.9B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
VOYA Investment Management withdrew a net $1.58B in Q2 2018, closing 117 positions and reducing 1,605 holdings. Its most notable exit was iShare MSCI Eurozone ETF, an estimated $111M position sold in full.
By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 21% a quarter earlier, followed by Consumer Discretionary and Healthcare.
Against the trend, VOYA Investment Management opened a new position in Jazz Pharmaceuticals worth $70.2M.
- VOYA Investment Management's largest Q2 2018 buy was Jazz Pharmaceuticals: 407,520 shares worth $70.2M.
- VOYA Investment Management added most to Alphabet (Google) Class A in Q2 2018, an estimated $278M increase.
- VOYA Investment Management's biggest Q2 2018 reduction was NetApp, cutting an estimated $302M.
- VOYA Investment Management fully exited iShare MSCI Eurozone ETF in Q2 2018, selling an estimated $111M.
- VOYA Investment Management's ten largest holdings make up 16% of its $47B portfolio in Q2 2018.
- VOYA Investment Management opened 139 new positions and closed 117 in Q2 2018.
- VOYA Investment Management's portfolio value rose 0.27% quarter-over-quarter to $47B.
Based on VOYA Investment Management's 13F filing for Q2 2018, filed 14 Aug 2018.